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KAJIAN FARMAKOLOGI DAN FITOKIMIA CLITORIA TERNATEA 
EKSTRAK  
   
 
ABSTRAK 
 
Dalam tesis ini, penyaringan fitokimia, antimikrob, antioksida dan aktiviti analgesik 
telah dijalankan ke atas pelbagai bahagian pokok C. ternatea dengan menggunakan 
pelbagai teknik bioassai dan model eksperimental yang sesuai. Penyaringan fitokimia 
menunjukkan kehadiran tanin, flobatanin, flavonoid, antrakuinon, alkaloid, saponin, 
glikosida kardiak, minyak meruap, steroid and terpenoid. Kandungan flavonoid dan 
fenol dalam pelbagai bahagian tumbuhan juga telah ditentukan. Analisis 
menunjukkan ekstrak bunga C. ternatea mengandungi kandungan fenol (104.77 ± 
2.64 mg asid gallik/g jisim tumbuhan) dan flavonoid (28.10 ± 4.13 mg katecin/g 
jisim tumbuhan) yang tinggi apabila dibandingkan dengan bahagian-bahagian lain. 
Hal ini telah terbukti apabila ekstrak bunga C. ternatea menunjukkan aktiviti 
antioksida yang paling tinggi (FRAP: 6.80 ± 0.32 μM Fe(II)/g jisim tumbuhan; 
DPPH IC50 : 9.17 ± 0.003 μg/mL) berbanding dengan bahagian-bahagian lain 
tumbuhan ini. Kaempferol-3-glukosida (K3G) yang merupakan sebatian flavonoid 
telah dikenalpasti sebagai salah satu bioaktif dalam ekstrak daun, batang dan bunga 
C. ternatea. Biaoktif ini mungkin merupakan penyumbang kepada aktiviti 
antioksida. Bagi penyaringan antimikrob in vitro, kedua-dua ekstrak daun dan akar 
C. ternatea menunjukkan aktiviti antimikrob yang tinggi. Lebih-lebih lagi, ekstrak 
daun C. ternatea ini menunjukkan aktiviti antikulat yang bagus terhadap Aspergillus 
niger dengan nilai perencatan minimum (MIC) 0.4 mg/mL dan nilai kepekatan maut 
minimum (MFC) 0.8 mg/mL. Hal ini telah terbukti apabila analisis mikroskop 
pengimbasan elektron (SEM) telah menunjukkan perubahan morfologi yang ketara 
ke atas dinding hifa dan konidiofor selepas pendedahan kepada ekstrak daun C. 
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ternatea berbanding dengan kumpulan kawalan. Sebelum kajian analgesik dan 
antikulat dikaji, ketoksikan akut ekstrak daun C. ternatea telah dijalankan dengan 
menggunakan mencit. Nilai LD50 ekstrak daun C. ternatea adalah melebihi daripada 
dos berat badan 2000 mg/kg yang menunjukkan esktrak daun C. ternatea ini berada 
pada zon selamat yang tinggi. Selanjutnya, model haiwan telah digunakan untuk 
mengkaji aktiviti analgesik dan antikulat ekstrak daun C. ternatea. Kedua-dua 
ekstrak daun dan akar C. ternatea menunjukkan aktiviti analgesik yang lebih baik 
apabila berbanding dengan kumpulan kawalan. Namun begitu, aktiviti analgesik 
adalah tidak setanding dengan tikus yang di rawat dengan morfina. Dalam kajian 
yang lain, aktiviti in vivo antikulat ekstrak daun C. ternatea telah dikaji dengan 
menggunakan mencit yang telah dijangkiti dengan A. niger. Aktiviti antikulat ekstrak 
daun C. ternatea adalah setanding dengan amfoterisin B. Kajian fraksinasi bioaktiviti 
berpandu menyarankan yang aktiviti antikulat ekstrak daun C. ternatea mungkin 
disebabkan oleh aktiviti sinergisme pelbagai bioaktif yang terdapat di dalam ekstrak 
tersebut. Fraksi bioaktif telah dianalisis selanjutnya dengan menggunakan 
kromatografi gas-spektroskopi jisim (GC-MS) dan spektroskopi inframerah (FTIR). 
Analisis ini menunjukkan yang fraksi bioaktif ini mungkin tergolong dalam 
kumpulan lipid dan/ atau terpenoid (seskuiterpena).   
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SOME PHARMACOLOGICAL AND PHYTOCHEMICAL STUDIES OF  
CLITORIA TERNATEA EXTRACTS 
 
ABSTRACT 
 
In this thesis, detailed work was carried out to explore and determine the 
phytochemical screening, potential anti-infective, antioxidant and analgesic 
properties of C. ternatea plant parts using various bioassays techniques and 
appropriate experimental models. The initial qualitative phytochemical screening 
shows that C. ternatea plant parts contain tannin, phlobatannin, flavonoid, 
anthraquinone, alkaloid, saponin, cardiac glycosides, volatile oils, steroids and 
terpenoids. The flavonoids and phenolic content of the various plant parts were also 
determined in the plant parts. Analysis shows that C. ternatea flower extract has both 
high phenolic (104.77 ± 2.64 mg GAE/g) and flavonoid (28.10 ± 4.13 mg CE/g) 
content than other plant parts. This is evident by the fact that C. ternatea flower 
extract exhibited the highest antioxidant activity (FRAP: 6.80 ± 0.32 μM Fe(II)/g ; 
DPPH IC50 : 9.17 ± 0.003 μg/mL) when compared to other parts of the plant. One of 
the bioactives identified in the flower extract was kaempferol-3-glucoside (K3G) 
which is a flavonoid compound. Kaempferol-3-glucoside was also found in C. 
ternatea stem and leaf. This could be one of the identified bioactives responsible for 
the antioxidant activity. As for the in vitro anti-infective screening, both leaf and root 
crude extracts demonstrated marked antimicrobial activities. Interestingly, the leaf 
extract demonstrated a remarkable antifungal activity against Aspergillus niger with 
a MIC and MFC of 0.4 and 0.8 mg/mL, respectively. This was evident by the 
scanning electron microscope (SEM) analysis which showed a marked 
morphological alteration of the A. niger hyphal wall and conidiophores after 
exposure to C. ternatea leaf extract when compared to control. The acute toxicity of 
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C. ternatea leaf extract was assessed in mice prior to antinociceptive and in vivo 
antifungal study. After oral administration in mice, the LD50 was found to be higher 
than 2000 mg/kg body weight which indicated some high level of safety for C. 
ternatea leaf extract. Subsequently C. ternatea leaf extract was further tested for its 
antinociceptive and in vivo antifungal activities in animal models. Studies in rats 
showed that both C. ternatea leaf and root extracts demonstrated antinociceptive 
activity at the studied dosage regimens when compared with control but the analgesic 
effect was not comparable to morphine treated rats. In another study, the in vivo 
antifungal activity of C. ternatea leaf extract was investigated in A. niger infected 
mice. C. ternatea leaf extract antifungal activity was comparable to clinically used 
amphotericin B. Bioactivity guided fractionation studies of the C. ternatea leaf 
extract suggest that the antifungal activity could be a synergistic activity of various 
bioactives presence in the extract. Further gas chromatography-mass spectroscopy 
(GC-MS) and fourier transform infrared (FTIR) analysis of the fractions indicated 
these bioactives could be lipids and/or terpenoids (sesquiterpenes) group of 
compounds. 
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CHAPTER 1 
 
1.0   INTRODUCTION 
 
Traditional medicinal practice has been known for centuries in many parts of the 
world for the treatment of various human ailments (Arora & Kaur, 2007). In 
developing countries, the World Health Organization (WHO) has estimated that 80% 
of the population rely almost on traditional medicine for their primary health care 
needs (World Health Organization, 2010). It is assumed that a major part of 
traditional therapy involves the use of plant extracts or their active principles 
(Ignacimuthu, Ayyanar, & Sivaraman, 2006). Hence, medicinal plants play a crucial 
role and constitute the backbone of traditional medicine (Mukherjee, 2002a).  
 
 Medicinal plants have formed an essential element of the materia medica of 
various formal and informal systems of medicine (Suneetha & Chandrakanth, 2006) 
as they have fitted the immediate personal need and are easily accessible and 
inexpensive (Mukherjee, 2002a). The demand for medicinal plants for medicinal 
purposes or as health supplements has been increasing worldwide and not to exclude, 
Malaysia has great potential to develop her abundant natural resources. However, the 
medicinal plants available have not been extensively exploited or studied (Jamal, 
2006). Among the promising medicinal plant that should receive more attention is 
Clitoria ternatea Linn. which is one of the medicinal plants used as an ingredient in 
‘Medha Rasayana’ a rejuvenating recipe for the treatment of neurological disorders 
in Ayurvedic traditional medicinal system (Sivaranjan & Balachandran, 1994). 
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 Clitoria ternatea Linn. (C. ternatea) belongs to family Fabaceae and is a very 
well known Ayurvedic medicine used for various different ailments. It has been used 
for centuries as antidepressant, antistress, anxiolytic, memory enhancer, nootropic, 
anticonvulsant, tranquilizer, sedative agent and also to treat fever, arthritis, eye 
ailments, indigestion, constipation, ear-diseases and swollen joints. C. ternatea 
extracts is known to possess a wide range of pharmacological activities which 
includes anti-inflammatory, analgesic, antipyretic, antimicrobial, insecticidal, 
diuretic, antidiabetic, local anesthetic, blood platelet aggregration-inhibiting and 
vascular smooth muscle relaxing properties (Mukherjee, V. Kumar, N. S. Kumar, & 
Heinrich, 2008). Various secondary metabolites such as polyphenolic flavonoids, 
anthocyanin glycosides, pentacyclic triterpenoids, phytosterols and fatty acids have 
been reported in this plant (Mukherjee, Kumar, & Heinrich, 2007). Flavonols i.e. 
kaempferols, quercetin and myricetin and their glycosides have been also isolated 
from this plant (Kazuma, Noda, & Suzuki, 2003).  
 
 A review paper on C. ternatea by Mukherjee et al. (2008) has well 
documented various traditional and potential pharmacological uses of this plant. An 
evaluation of C. ternatea for its potential anti-inflammatory, antimicrobial, central 
nervous system (CNS) related effects are imperative for development of an effective 
natural remedy. Previously, finotin (a protein) isolated from C. ternatea was found to 
be potent inhibitor against various important plant fungal pathogens (Kelemu, 
Cardona, & Segura, 2004). Though the antifungal activity is not of immediate 
relevance to humans, nevertheless the finding indicates its possible antifungal 
effects. With this in view, it has prompted us to systematically evaluate and 
determine antimicrobial spectrum of C. ternatea against human pathogenic 
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microorganisms. Further to this, numerous studies have reported the presence of 
flavonoids and phenolic compounds in C. ternatea plant parts thus these suggest their 
potential applications as antimicrobial, antioxidant, anti-inflammatory, 
anticarcinogen, antiallergic, antiviral, immune-stimulating agents (Rice-Evans, 
Miller, & Paganga, 1996). Despite these activities, there were also studies that 
demonstrated the analgesic activity of methanolic C. ternatea roots extract using 
acetic-acid induced writhing test and ethanolic C. ternatea aerial extracts 
(Parimaladevi, Boominathan, & Mandal, 2003; Kulkarni, Pattanshetty, & Amruthraj, 
1988) in rats.  
 
 As of to date not much work was carried out on  the  antimicrobial activity of 
various C. ternatea plant extracts on human pathogenic microorganism, while  
studies on antioxidant activity was limited only  to water extract of C. ternatea plant 
parts. In addition, analgesic activity of various C. ternatea plant parts crude extracts 
have been also documented but using limited experimental models. Therefore in this 
thesis, detailed work was undertaken to explore and determine the potential 
toxicology, anti-infective, antioxidant and analgesic properties of C. ternatea plant 
parts using various bioassays techniques and appropriate experimental models. In 
this thesis, the chemical constituents responsible for its antifungal activity was 
isolated and identified.  
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1.1   Objectives 
The objectives of the work carried out in this thesis are as follows: 
• To obtain various crude extracts from C. ternatea leaves, stems, flowers, seeds 
and roots by means of maceration extraction method. 
• To conduct qualitative phytochemical, antimicrobial and antioxidant assays on 
various crude extracts of C. ternatea leaf, stem, flower, seed and root. 
• To evaluate the antinociceptive activities of C. ternatea leaf and root extracts 
using hot plate, tail-flick and formalin test models. 
• To conduct oral acute toxicity in mice using C. ternatea leaf extract. 
• To perform Scanning Electron Microscopy (SEM) and in vivo studies of C. 
ternatea leaf extract against Aspergillus niger. 
• To identify the antifungal active fraction(s) from C. ternatea leaf extract. 
 
 
CHAPTER 2 
 
2.0   LITERATURE REVIEW 
 
2.1   Herbal medicine 
Plants, parts of plants and isolated phytochemicals have been used since ancient 
times for prevention and treatment of various health ailments (Sahoo, Machikanti, & 
Dey, 2010). Plants still contribute significantly to health care sector, in spite of the 
great advances observed in modern medicines in recent decades (Calixto, 2000). 
Plants may be defined as food, functional food, dietary supplement or as herbal 
medicine (Sahoo et al., 2010). Herbal medicines include herbs, herbal materials, 
herbal preparations and finished herbal products that contain active ingredients of 
plant parts or other plant materials or combinations (World Health Organization, 
2010). Worldwide, it is estimated that 25% of the drugs prescribed are derived from 
plants. Besides this, 11% of the total 252 drugs in WHO’s essential medicine list is 
exclusively of plant origin (Rates, 2001).  
 
 Herbal drugs can be categorized into three types based on the nature of their 
active metabolites. The first category of plant drugs are usually simple botanicals 
employed in their crude form. Examples are opium, belladonna, aloe and cinchona. 
The second category of herbal drugs is represented by the active constituents (pure 
molecules) isolated after the processing of plant extracts. Some of the prominent 
examples are reserpine from Rauvolfia, quinine from Cinchona and taxol from Taxus 
species. The third category of herbal drugs is drugs with acute and chronic toxicity 
data available. Examples are mineralo-herbal drug Amlena and green tea extract 
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(Veregen) (Iwu, Duncan, & Okunji, 1999; Chandra, Sachan, Ghosh, & Kishore, 
2010; Wu, Ghantous, & Birnkrant, 2008).  
   
 WHO (2003) classified the herbal drugs into four categories such as 
indigenous herbal medicines, herbal medicine in systems, modified herbal medicines 
and imported products with an herbal medicine base. Indigenous herbal medicines 
are used in local community and are well known in terms of their composition, 
treatment and dosage. Herbal medicines in systems (Ayurveda, Unani and Siddha) 
have been in use for a long time. Modification of indigenous herbal medicine or 
herbal medicines in systems in terms of shape or form, dosage form, mode of 
administration, herbal medicinal ingredients, methods of preparation and medical 
indications represents modified herbal medicines.  
 
 In developing countries, WHO has estimated that the 80% of the population 
rely almost on traditional medicine for their primary health care needs. Herbal plants 
play a crucial role and constitute the backbone of traditional medicine (Mukherjee, 
2002a). The demand for medicinal plants for medicinal purposes or as health 
supplements has been increasing worldwide and not to exclude, Malaysia has great 
potential to develop her abundant natural resources. However, the medicinal plants 
available herein have not been extensively exploited or studied (Jamal, 2006). 
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2.2   Plant introduction 
 
2.2.1   Clitoria ternatea 
Clitoria ternatea Linn, is a very renowned Ayurvedic medicine used to treat various 
ailment. C. ternatea belongs to family Fabaceae. It is commonly known as butterfly 
pea, conch flower, shankapushpi and bunga telang. In Indian traditional medicine, it 
is known as Aparajit (Hindi), Aparajita (Bengali) and Kankattan (Tamil). Initially, C. 
ternatea is a native of the Caribbean, Central America and Mexico and currently it is 
well distributed in India subcontinent, Phillipines, Malaysia and other tropical Asian 
countries, South and Central America, Madagascar and Caribbean (Mukherjee et al., 
2008).   
 
The scientific name of the genus was derived from Greek kentron, a spur, 
prickle, sharp point, the center, and sema, a signal, referring to the spurred standard 
petal (Austin, 2004). Meanwhile, its species name was named after the island of 
Ternata in Moluccaa archipelago (Mukherjee et al., 2008).  
 
2.2.2   Botany and pharmacognosy of C. ternatea 
C. ternatea (Figure 2.1) is an ornamental perennial climber which climbs up to 2-3 m 
in height, grows wild and also in gardens. It bears conspicuous blue or white flowers 
resembling a conch-shell. Though it is presumably of American origin, today it is 
cultivated and naturalized throughout the humid tropics of the old and new world 
below 1600 m elevation (Morton, 1981).  
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The plant possesses imparipinnate leaves consisting of five to seven leaflets, 
6-13 cm long. The leaflets are oblong or ovate, 2-5 cm long and subcoriaceous, 
rubiaceous stomata with wavy cell walls are present on both upper and lower 
epidermis of the leaflets (Mukherjee et al., 2008). 
 
The plant bears papilionaceous, axillary, solitary flowers. The flowers are 
available in white or bright blue in colour with a yellow or orange center (Figure 
2.2). C. ternatea pods are flat, nearly straight, sharply beaked and are 5-10 cm long. 
Each pod can bear 6-11 seeds. The seeds are yellowish-brown or blackish in color 
and subglobose or oval in shape (Mukherjee et al., 2008). 
 
 The C. ternatea root system consists of a fairly stout taproot with few 
branches and many slender lateral roots. The thick horizontal root can grow up to 
more than 2 m long, bears one to several purplish, glaucous, wiry stems. The root is 
woody, cream white with a few lenticels united to form transverse cracks. The fresh 
root is slightly bitter and acrid in taste (Mukherjee et al., 2008). 
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Figure 2.1:  C. ternatea Linn plant. 
 
 
 
 
 
Figure 2.2:  C. ternatea Linn flower in blue colour. 
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2.2.3   Traditional uses of C. ternatea 
C. ternatea has been used for centuries in traditional Ayurvedic system of medicine 
to treat several diseases. C. ternatea has been used as an ingredient in ‘Medhya 
Rasayana’ a rejuvenating recipe used for treatment of neurological disorders and 
strengthens a person’s intellect. In Ayurveda, the drug ‘Sankhapushpi’ consists of the 
roots and seeds of C. ternatea and is used as a ‘tonic of the nerves’, alterative and 
laxative (Mukherjee et al., 2008). 
 
The roots and leaves are used in the treatment of a number of ailments 
including body aches, infections, urinogenital disorders, and as an anthelmentic and 
antidote to animal stings. In addition, the roots have an acrid and bitter taste and are 
credited with diuretic, purgative and laxative properties. The root is used in the 
treatment of various diseases, like indigestion, constipation, fever, arthritis and eye 
ailments. It is also employed in cases of ascetics, enlargement of the abdominal 
viscera, sore throat, skin diseases and chronic bronchitis. The decoction or powder of 
the root is given in rheumatism, and ear-diseases (Mukherjee et al., 2008). 
 
Powdered seeds are mixed with ginger and given as laxative, the action, 
however, is accompanied by gripping in lower abdomen. The seeds are considered 
for colic, dropsy and enlargement of abdominal viscera; they are also used in swollen 
joints. The root, stem and flower are recommended for the treatment of snakebite and 
scorpion sting in India (Mukherjee et al., 2008).   
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2.2.4   Other uses 
C. ternatea is a highly palatable forage legume generally preferred by livestock over 
other legumes. It exhibits excellent re-growth after cutting or grazing within short 
period of time and produce high yields. It is grown with tall grasses for rotational 
grazing, hay or silage. It is grown either alone or with other perennial grasses in Uttar 
Pradesh, Gujarat, Maharashtra, Madhya Pradesh, Andhra Pradesh, Punjab, Rajasthan, 
Tamilnadu and Karnataka in India. Besides suppressing many perennial weeds, it 
enriches the soil by fixing nitrogen. It is also used as drought-resistant pasture in arid 
and semi-arid regions (Mukherjee et al., 2008).  
 
 Butterfly pea is also used as a cover crop and green manure. It is also grown 
as ornamental plant due to its attractive flower colours (Kalamani & Michael, 2003). 
In Kerala (India) and Philippines, the young shoots, leaves, flowers and tender pods 
are eaten as vegetable. In Malaysia, the leaves are traditionally employed to impart a 
green colour to food and the flowers to impart a bright blue colour to rice cakes 
(Mukherjee et al., 2008). The medicinal potential of this use in Malaysian traditional 
practice warrants investigation.  
 
2.2.5   Pharmacological activities of C. ternatea 
C. ternatea has been widely screened for various pharmacological activities. It has 
been  documented for its neuropharmacological actions such as nootropic, antistress, 
antidepressant, anticonvulsant, enhancing acetylcholine content, anxiolytic, 
tranquilizing and sedative activities which justify its use in CNS diseases in 
Ayurvedic system of medicine. It has antimicrobial, antipyretic, anti-inflammatory, 
analgesic, diuretic, local anesthetic, antidiabetic, insecticidal, blood platelet 
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aggregation inhibiting and vascular smooth muscle relaxant properties (Mukherjee et 
al., 2008). The various reported pharmacological activities of C. ternatea (Table 2.1) 
have been summarized below. 
 
Table 2.1:  Pharmacological activities of C. ternatea Linn. (Source: Mukherjee et al., 
                  2008). 
 
  
 Though the pharmacological activities are thoroughly documented but the 
bioactives responsible for its pharmacological activities are still lacking. Studies on 
the absorption and disposition of this bioactives in preclinical and clinical trials are 
imperative (Mukherjee et al., 2008). Therefore C. ternatea merits further 
phytochemical, pharmacological and clinical investigations for development of 
therapeutically effective lead compounds or standardized extracts. In this thesis, the 
phytochemical, toxicity, antioxidant, analgesic and antimicrobial investigation were 
carried out for C. ternatea.  
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2.3   Quality control of extracts 
Herbal extracts are in great demand for primary healthcare in developed as well as 
developing countries. This is because of their extensive biological activities, lesser 
cost and high safety margins. The most important challenges faced by herbal extracts 
formulations arise because of their lack of standardization (Palav & D’mello, 2006). 
Various factors such as the age of the plant, part of the plant used, time of harvest, 
soil conditions, weather conditions, extraction and drying methods, type of solvents 
used, etc. greatly affects the quality, composition and bioactivity of the herbal 
extracts (Hendriks, Juarez, Bont, & Hall, 2005). Since these factors affect the end 
composition and consistency of the finished product, the standardization and quality 
control of the herbal extracts are required.  
 
  With the tremendous growth of herbal extracts, the health authorities and the 
public are concern on the quality control of herbal extracts used for treatment (Fan, 
Cheng, Ye, Lin, & Qian, 2006). The herbal extracts have distinctive characteristics 
from synthetic drugs in which the herbal extracts contain more than one active 
compound and the active principle is frequently unknown (Sahoo et al., 2010). 
Currently, the analysis of one or more selected marker compounds is used to predict 
the quality of herbal extracts. Ideally, the marker compounds could be responsible 
for the efficacy and activity of the herbal extract. However, the selected marker 
compounds that are often chemical characteristics of the herb may not be related to 
the bioactivity of the herb. Furthermore, the synergistic effect of several compounds 
may also contribute to the bioactivity of certain plant. The common practice of using 
one marker compound neglects the synergistic effect. As an outcome, the marker-
based approach is found to be incomplete and unsatisfactory method for quality 
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control of herbal materials (Hendriks et al., 2005). Liang, Xie, & Chan (2004) have 
stated that this kind of determination does not give a complete picture of a herbal 
product because multiple constituents are usually responsible for its therapeutic 
effects.  
 
 Quality control of herbal preparations is the requirement of credible clinical 
trials. As stated in the draft guidelines by United States Food and Drug 
Administration (USFDA) and The European Agency for the Evaluation of Medicinal 
Products, various aspects of analysis must be performed for the purpose of 
certification of herbal preparations (Ong, 2004). The standardization methods should 
take into consideration all aspects that contribute to the quality of herbal drugs. The 
methods include correct identity of the sample, organoleptic evaluation, 
pharmacognostic evaluation, volatile matter, quantitative evaluation (ash values, 
extractive values), phytochemical and biological activity evaluation. The herbal 
preparations should also be tested for the presence of xenobiotics, microbial 
contaminations, toxicity testing, pesticides, arsenic and heavy metals contents 
(Rajani & Kanaki, 2008; Mukherjee, 2002b).   
 
 Among the various quality control methods, the chromatographic 
fingerprinting has gained a lot of attention recently. Various bodies like WHO, 
USFDA, European Medicines Agency (EMEA), German Commission E, British 
Herbal Medicine Association, Indian Drug Manufacturers and others have accepted 
the usage of chromatographic fingerprinting to assess and standardize the herbal 
medicines (Fan et al., 2006). Chromatographic fingerprinting is a chromatogram that 
represents the chemical characteristics or pattern of a herbal extract (Cheng, Chen, & 
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Tong, 2003). The chemical profiling is a versatile technique and is of good use in 
standardization method (Mukherjee, 2002e). The common analytical techniques used 
are Thin Layer Chromatography (TLC), High Performance Liquid Chromatography 
(HPLC), Gas Chromatography-Mass Spectroscopy (GC-MS), Liquid 
Chromatography Mass Chromatography (LC-MS), near infrared (NIR) and 
spectrophotometer. A chemical fingerprint by hyphenated chromatography is used as 
the primary tool for quality control of herbal medicines (Liang et al., 2004) and serve 
as guideline to the phytochemical profile of the drug in ensuring the quality (Rajani 
& Kanaki, 2008). Also, the full herbal product can be regarded as the active 
compound (Liang et al., 2004). Chromatographic fingerprinting has potential to 
determine the identity, authencity and batch-to-batch consistency of herbal 
medicines. Generally, samples with similar chromatographic fingerprint have similar 
properties (Fan et al., 2006). The chromatographic techniques enable rapid, 
reproducible and efficient semiquantitative and quantitative analysis of the chemical 
constituents in complex mixtures (Rajani & Kanaki, 2008).  
 
2.4   Phytochemistry 
Phytochemistry is termed as plant chemistry. The phytochemistry studies are 
essential for various research disciplines such as plant physiology, plant 
biochemistry, chemosystematics (often referred to as chemotaxonomy), plant 
biotechnology and pharmacognosy (Hajnos, Sherma, & Kowalska, 2008). 
Phytochemistry studies are concerned with a variety of organic substances (primary 
and secondary metabolites) present in plant and deal with the chemical structures of 
these substances, their biosynthesis, turnover, metabolism, natural distribution and 
biological function (Harborne, 1973a). 
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Plants are biosynthetic producer of chemical substances such as primary and 
secondary metabolites (Nyiredy, 2004). Primary metabolites include amino acids, 
simple sugars, lipids and nucleic acids which are necessary for cellular processes and 
are found in all plant species (Wink, 2006; Zwenger & Basu, 2008). Secondary 
metabolites (SMs) differ between species and occur in mixtures. Unlike primary 
metabolites, SMs are not essential for energy metabolism and life but they play an 
important role for the ecological fitness and survival of the plants (Wink, 2006). 
Plant SMs are usually categorized according to their biosynthetic pathways. 
Phenolics, terpenes and steroids, and alkaloids are the three large molecule families 
that are generally considered (Bourgaud, Gravot, Milesi, & Gontier, 2001). Other 
SMs include lignins, flavonoids, amino acid derivatives, organic acids, polyketids 
and sugar derivatives (Nyiredy, 2004).    
 
Plants SMs serve important biological and ecological roles mainly as 
chemical messengers and defensive compounds (Jones & Kinghorn, 2005). These 
molecules are able to protect plants from pathogens (phytoalexins), therefore 
expressed as antibiotic, antifungal and antiviral. They also act as toxic or anti-
germinative for other plants (allelopathy) (Bourgaud et al., 2001). Notably, SMs 
constitute important ultraviolet (UV) absorbing compounds, thus preventing serious 
leaf damage from the light (Li, Ou-Lee, Raba, Amundson, & Last, 1993).   
 
Plant SMs have been used in traditional medicines for centuries. Currently, 
SMs are used in pharmaceutics, cosmetics, fine chemicals and also in nutraceutics 
(Bourgaud et al., 2001). In western countries, studies have shown that 25% of the 
 16
molecules used in pharmaceutical industry are of natural plant origin (Payne, Bringi, 
Prince, & Shuler, 1991). 
 
2.4.1   Sample selection, collection and identification    
In drug discovery from plants, four standard approaches are available for selecting 
plants: (1) follow-up of ethnomedicine or traditional uses of plants used as food, 
medicine, or poison based on literature review or interviews, (2) random or 
systematic collection of a biodiverse set of plant samples, typically from an 
ecological region that is comparatively uncharted as regard to secondary metabolite 
production, (3) the selection of species based on phylogenetic relationship to a 
species known to produce a compound or compound class of interest, (4) follow up 
of species based on reports of biological activity in the literature (Jones & Kinghorn, 
2005). A fifth, non-systematic approach is serendipity, where plant is selected based 
on ethnomedical use, but the bioactivity of the plant is new and unexpected (Cos, 
Vlientinck, Berge, & Maes, 2006). 
 
 In phytochemical analysis, the botanical identity of the plants studied should 
be authenticated to identify and confirm the plant identity (Harborne, 1973a). The 
voucher specimens (which include reproductive organs, when feasible) should be 
deposited in the herbarium of major institutions. The identity of the material should 
include observations such as its habitat, local uses of the species, microenvironment 
(e.g. shaded vs. sunny location), overall state of the plant health, reproductive stage 
and also other information that may be useful for future investigations (Jones & 
Kinghorn, 2005).   
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2.4.2   Extraction of plant constituents 
The most crucial step in drug discovery is processing of the plant material. During 
the preparation of the extract, careful measurements must be adopted to ensure the 
potentially active constituents are not lost, destroyed or altered. Extraction 
procedures such as maceration, percolation and infusion are the traditional 
techniques used for the extraction of medicinal plants (Cos et al., 2006). The sole 
purpose of such basic extraction procedures is to obtain the therapeutically desired 
portion and eliminate the inert material by treatment with a selective solvent known 
as menstruum (Singh, 2008). In pharmaceutical industry, extraction techniques such 
as maceration, infusion, percolation, digestion, decoction, hot continuous extraction 
(Soxhlet), aqueous-alcoholic extraction by fermentation, counter-current extraction, 
microwave-assisted extraction, ultrasound extraction (sonication) and supercritical 
fluid extraction are generally used (Handa, 2008). 
 
2.4.2 (a) Maceration extraction 
Specific extraction procedures are usually employed to produce enriched extracts 
when a particular phytochemical constituent or compound class is targeted to be 
extracted for an investigation (Jones & Kinghorn, 2005). In this thesis, the 
maceration extraction method was used. Maceration is the extraction process of drug/ 
plant extracts with a solvent with several daily shakings or stirrings at room 
temperature. Maceration is one of the most widely used extraction method and can 
be carried out with small samples (Mukherjee, 2002c). 
 
 The maceration system is static except during occasional shaking. The 
occasional shaking removes the concentrated solution accumulating around the 
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surface of the particles and mixes it with the rest of the menstruum whereby it brings 
fresh menstruum to the particle surface for further extraction. The shaking also 
assists in diffusion. A closed system is used as it prevents the evaporation of 
menstruum over a prolonged period and this avoids batch-to-batch variation 
(Sambamurthy, 2005). 
 
2.4.2 (b)   Types of solvent 
Interactions between the solvent and solute can be assessed by several indicators for 
example the dipole moment, polarity index, viscosity and surface tension (Lalman & 
Badley, 2004). The chemical properties of frequently used solvent for extraction 
purpose are tabulated in Table 2.2.   
 
Table 2.2:  Chemical properties of solvents. 
Types of 
solvent 
Polarity 
index a 
Surface 
tension 
(mN/cm) b 
Viscosity 
(mPa/s) c 
Dipole 
moment 
(Debye) d 
n-Hexane 
n-Butanol 
Chloroform 
Ethyl acetate 
Methanol 
Ethanol 
Water 
0 
4.0 
4.1 
4.4 
5.1 
5.2 
9.0 
17.9 
24.2 
26.5 
23.1 
22.3 
21.9 
72.8 
0.30 
0.41 
0.53 
0.43 
0.54 
1.08 
0.89 
0 
1.521 
1.155 
1.831 
1.621 
1.550 
1.870 
a Retrieved from Gupta et al., 1997 and Synder 1974 
b Retrieved from Markom et al., 2007 
c Retrieved from Synder 1974 
d Retrieved from Sheng et al., 2011 
 
 
 The dipole moment measures the polarity of a molecule as a net sum of the 
dipole moments of its polar bonds (Sheng, Vannela, & Rittman, 2011). The 
interaction between the solvent and solute also resulted in the overall increase of 
dipole moment for the solution (Markom, Hasan, Daud, Singh, & Jahim, 2007). 
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 The polarity index is defined as the measure of the ability of the solvent to 
interact with various polar test solutes, and it increases with solvent polarity. The 
higher polarity index value demonstrates their stronger capability do dissolve more 
polar solutes. Vice versely, solvents with lower polarity index value exhibits weaker 
ability in interacting with polar solutes. Solvents with low viscosity have low density 
and high diffusivity, and can easily diﬀuse into the pores of the plant materials 
(Sheng et al., 2011). Temperature is another important factor that contributes to the 
interaction between the solvent and solute. High temperature breaks the solute-
matrix, reduces the viscosity and surface tension and therefore improves the 
extraction yield (Markom et al., 2007). However, higher temperatures are avoided as 
it can cause degradation of thermolabile compounds (Sheng et al., 2011).  
  
2.4.3 Purification of plant constituents 
Purification of the extract is the next step and a vital one in the sample preparation 
after the extraction process. The existing purification method includes analytical and 
preparative process. In analytical purification, the most widely used method is the 
solid-phase extraction (SPE) meanwhile in preparative purification, the liquid-liquid 
extraction method is used (Nyiredy, 2004). As for liquid-liquid extraction method 
extraction is based on the partition between the immiscible solvents (Nyiredy, 2004). 
The extract usually dissolved in water is mixed with another solvent which does not 
mix with the aqueous phase. The plant constituents solubilise in each of the phases 
and after a time, equilibrium between the phases is reached. The solvent added is 
replaced with another immiscible solvent to the aqueous phase (Houghton & Raman, 
1998b). The frequently used immiscible phases include diethyl ether/water, 
chloroform/water, ethyl acetate/water and dichloromethane/water (Nyiredy, 2004). 
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Vigorous mixings of the two phases in a stoppered separating funnel can shorten the 
time taken for the equilibrium to be achieved (Houghton and Raman, 1998b). In this 
thesis, the liquid-liquid extraction method was used to purify the C. ternatea 
constituents. 
 
2.4.4   Separation and identification of plant constituents    
In search of plant active constituents, various combinations of separation methods 
such as extraction, purification and chromatography are essential. The first two 
methods belong to sample preparation meanwhile the chromatographic methods are 
used to evaluate the qualitative and quantitative analysis, as well as for isolation 
purposes (Nyiredy, 2004). In this thesis, bioassay guided TLC was used to separate 
and purify the bioactive fraction. Subsequently the GC-MS and Fourier Transform 
Infrared Red (FTIR) were used to identify the purified bioactive fraction. 
 
2.4.4 (a)   Thin Layer Chromatography (TLC)  
TLC is one of the most extensively used chromatography methods in an organic 
laboratory (David, 2001). The TLC is a quick method that would separate small 
quantity of compounds (Raaman, 2008a). TLC is simple, low in cost, flexible and 
allows multiple detections. It is also used as an ideal screening method in chemical 
and biological analysis, provides identification and qualitative results and determines 
adulteration together with quantitative and semi-quantitative determination. 
Furthermore, TLC is the only technique in which all the components of the sample 
can be displayed in the chromatogram. In contrast, Gas Chromatography (GC) is 
selective and not all of the compounds in the sample are included in the display 
(Marston, 2007).  
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  TLC is classified as solid-liquid chromatography since a solid is used as the 
stationary phase and a liquid as the mobile phase. The separation of compounds in a 
sample involves the adsorption principle, thus TLC is regarded as adsorption 
chromatography and the principle is exactly the same as column chromatography. 
The compounds are separated due to their different adsorption strengths to the 
adsorbent (David, 2001). 
 
 In simple terms, the mobile phase solvents desorb and dissolve the 
compounds from their binding to the adsorbent and carry the compounds upwards, in 
the direction of the movement of the solvent. Thus the compounds move due to the 
dynamic adsorption and desorption (David, 2001). Compounds which have great 
affinity for the mobile phase is desorbed and moved from the stationary phase and 
deposited near the solvent front whereas compounds with a lower affinity is 
deposited nearer to the origin (R. J. Hamilton & S. Hamilton, 1987). The distance 
travelled by the compounds are measured and reported as Rf value where 
       Rf    =     Distance moved by the compound   
     Distance moved by the solvent front 
 
2.4.4 (b)   Gas Chromatography-Mass Sectroscopy (GC-MS) 
GC-MS is an essential analytical technique used for qualitative and quantitative 
analysis of solid, liquid and gaseous samples (Raaman, 2008b) and also to 
characterize and identify the volatile organic compounds in complex mixtures (Zhu 
et al., 2009). This technique also provides information about the structure of a wide 
variety of complex molecular structure, the isotopic ratios of atoms in samples and 
the structure and composition of solid surfaces. In general, the samples injected are 
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converted into gaseous ions and then separated on the basis of their mass-to-charge 
ratio (Raaman, 2008b). 
 
 In gas chromatography, the sample is vapourised and injected onto the head 
of the chromatographic column (Raaman, 2008b). The column contains a liquid 
stationary phase which is either coated on to the walls of a narrow column (as in 
capillary column GC) or on to small particles of an inert, solid material which is 
packed in wider column (packed-column GC) (Houghton & Raman, 1998c). The 
samples are transported through the column by the flow of an inert gas (often 
nitrogen, helium and argon) mobile phase. The components of the mixtures are 
distributed between a gas and a liquid phase (Raaman, 2008b) and separated due to 
differences in their relative affinities for the liquid and gaseous phases (Houghton & 
Raman, 1998c). The rate of migration of the components is determined by how much 
of it is distributed into the gas phase. The higher the percentage of material in the gas 
phase, the faster it will migrate. For example, a component that distributes itself 
100% into the gas phase will migrate at the same rate as the flowing gas. On the 
other hand, a species that distributes 100% into the stationary phase, will not migrate 
at all. Components that distribute themselves partly in both phases will migrate at an 
intermediate rate (Raaman, 2008b).    
 
 The primary criterion for the peaks identification is the retention time (tR) 
which is termed as the time between sample injection and an analyte peak reaching a 
detector at the end of the column (Hu et al., 2006; Raaman, 2008b). The 
chromatographic detector (mass spectrometer) provides additional data for the 
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